Soleno Therapeutics Hit With Securities Fraud Lawsuit Over Phase 3 Trial Misrepresentations
Law firm Bernstein Liebhard files securities fraud class action against $SLNO, citing alleged misrepresentations regarding Phase 3 DCCR clinical trial program.
TCOMGOSLNOsecurities fraudclass action lawsuit



